ROLE OF PLATELETS AS A FACTOR AGGRAVATING CEREBRAL ISCHEMIA

概要

論文の詳細を見る
In order to clarify the role of platelets as a factor aggravating cerebral ischemia, an experimental model of ischemia was investigated using thrombocytopenic rats. In addition, the prostacyclin derivative (OP-41483) and the thromboxane A_2 synthetase inhibitor (OKY-046), both of which inhibit platelet aggregation, were tested for possible beneficial effects on cerebral ischemia. Cerebral ischemia was produced in spontaneously hypertensive male rats using bilateral common carotid artery ligation (BLCL). Thrombocytopenia was produced with an antiplatelet antiserum which reduced the platelet count to less than 6×10^4/μl by 24h. OP-41483 was administered four times hourly (500ng/kg ×4, i.p.), beginning 1h prior to BLCL. Similarly. OKY-046 was injected four times hourly (10mg/kg ×4, i.p.). Brain metabolites such as ATP, lactate and pyruvate and water content were determined after 3h of cerebral ischemia. Brain levels of ATP in the ischemic rats with thrombocytopenia were higher than those of the ischemic rats without thrombocytopenia. In addition, thrombocytopenia reduced the increase of lactate and water content in the ischemic brain. Animals treated with OP-41483 also maintained higher levels of ATP and lower levels of lactate and water compared to animals given a vehicle. OKY-046 significantly reduced brain water content, but had no effect on the ischemic alteration of brain metabolite levels. These results indicate that platelets play an important role in the progression of metabolic change during ischemia.
社団法人日本循環器学会の論文
1990-12-20

ROLE OF PLATELETS AS A FACTOR AGGRAVATING CEREBRAL ISCHEMIA

スポンサーリンク

概要

著者

関連論文

スポンサーリンク